Sanara MedTech (SMTI) director Myers received 1,975 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Keith G Myers (director at Sanara MedTech Inc., SMTI) reported that they received 1,975 shares on Nov 11, 2024. After these transactions the filing shows 1,975 shares held directly.
- Reporting person
- Myers Keith G
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 11, 2024 | Grant or award (A) | Common Stock1 | +1,975 | - | - | 1,975 direct |
Holdings before and after
- Common Stock: 0 to 1,975 direct
Footnotes from the filing
- 1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the Company ) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the date of the Company's next annual shareholder meeting, provided that the reporting person is providing certain services to the Company through such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Myers report in this SMTI Form 4?
Keith G Myers (director at Sanara MedTech Inc., SMTI) reported that they received 1,975 shares on Nov 11, 2024. After these transactions the filing shows 1,975 shares held directly.
How many SMTI shares does Myers hold after this filing?
The filing shows 1,975 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for SMTI
Earlier insider filings at SMTI
- Jun 14, 2024Director Salamone Ann Beal was granted 2,949 shares, increasing direct ownership by 17% to 19,895 units (SEC Form 4)
- Jun 14, 2024Director Tanzberger Eric D was granted 3,768 shares, increasing direct ownership by 37% to 14,068 units (SEC Form 4)
- Jun 14, 2024Director Ortwein Sara N was granted 3,440 shares, increasing direct ownership by 24% to 17,522 units (SEC Form 4)
- Jun 14, 2024Director Desutter Robert Andrew was granted 3,932 shares, increasing direct ownership by 25% to 19,455 units (SEC Form 4)
- Jun 14, 2024Chief Executive Officer Nixon Ronald T was granted 10,812 shares, increasing direct ownership by 24% to 56,508 units (SEC Form 4)
Keep researching SMTI
- SMTI insider tradesEvery buy and sale reported by Sanara MedTech Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- SMTI earnings historyPast Sanara MedTech Inc. earnings releases, newest first.
- SMTI financial statementsRevenue, profit, cash flow and balance sheet from Sanara MedTech Inc.'s SEC filings.
Quantisnow market dataNASDAQ
SMTI
Sanara MedTech Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
Get push alerts for SMTI
Full SMTI profile on Quantisnow Follow SMTI and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time